****************************************************************** * Cyclophilin-type peptidyl-prolyl cis-trans isomerase signature * ****************************************************************** Cyclophilin [1] is the major high-affinity binding protein in vertebrates for the immunosuppressive drug cyclosporin A (CSA). It exhibits a peptidyl- prolyl cis-trans isomerase activity (EC 5.2.1.8) (PPIase or rotamase). PPIase is an enzyme that accelerates protein folding by catalyzing the cis-trans isomerization of proline imidic peptide bonds in oligopeptides [2]. It is probable that CSA mediates some of its effects via an inhibitory action on PPIase. Cyclophilin is a cytosolic protein which belongs to a family [3,4,5] that also includes the following isozymes: - Cyclophilin B (or S-cyclophilin), a PPIase which is retained in an endoplasmic reticulum compartment. - Cyclophilin C, a cytoplasmic PPiase. - Mitochondrial matrix cyclophilin (cyp3). - A PPIase which seems specific for the folding of rhodopsin and is an integral membrane protein anchored by a C-terminal transmembrane region. This protein was first characterized in Drosophila (gene ninaA). - A bacterial periplasmic PPiase (gene ppiA). - A bacterial cytosolic PPiase (gene ppiB). - Natural-killer cell cyclophilin-related protein. This large protein (about 160 Kd) is a component of a putative tumor-recognition complex involved in the function of NK cells. It contains a cyclophilin-type PPiase domain. The sequences of the different forms of cyclophilin-type PPIases are well conserved. As a signature pattern, we selected a conserved region in the central part of these enzymes. -Consensus pattern: [FY]-x(2)-[STLV]-x-F-H-[RH]-[LIVM](2)-x(2)-F-[LIVM]-x-Q- [AG]-G -Sequences known to belong to this class detected by the pattern: ALL, except for yeast CYP4. -Other sequence(s) detected in SWISS-PROT: NONE. -Note: FKBP's, a family of proteins that bind the immunosuppressive drug FK506, are also PPIases, but their sequence is not at all related to that of cyclophilin (see the section on FKBP). -Last update: June 1994 / Text revised. [ 1] Stamnes M.A., Rutherford S.L., Zuker C.S. Trends Cell Biol. 2:272-276(1992). [ 2] Fischer G., Schmid F.X. Biochemistry 29:2205-2212(1990). [ 3] Trandinh C.C., Pao G.M., Saier M.H. Jr. FASEB J. 6:3410-3420(1992). [ 4] Galat A. Eur. J. Biochem. 216:689-707(1993). [ 5] Hacker J., Fischer G. Mol. Microbiol. 10:445456(1993).